Stockreport

IMUNON to Present Phase 3 Ovarian Cancer Study of IMNN-001 at ESMO Congress

Imunon, Inc.  (IMNN) 
PDF Prestigious European Society for Medical Oncology Conference “trials-in-progress” session Pivotal OVATION 3 trial of its DNA-mediated immunotherapy in newly diagnosed p [Read more]